IL194398A0
(en )
2009-08-03
Bisadenosine compounds as adenosine a2a receptor agonists
GB0607196D0
(en )
2006-05-17
G-protein coupled receptor agonists
GB0720390D0
(en )
2007-11-28
G-Protein coupled receptor agonists
GB0720389D0
(en )
2008-11-12
G-Protein Coupled Receptor Agonists
HK1131392A1
(en )
2010-01-22
Adenosine derivatives as a2a receptor agonists
HK1162139A1
(en )
2012-08-24
Myocardial perfusion imaging using adenosine receptor agonists
HRP20151108T1
(en )
2015-11-20
Nogo receptor antagonists
EP2041120A4
(en )
2010-12-22
Melanocortin receptor agonists
IL201234A0
(en )
2010-05-31
Adenosine a2a receptor antagonists
EP2151236A4
(en )
2013-01-16
G-protein-conjugated receptor agonist
EP2173174A4
(en )
2010-08-04
Farnesoid x receptor agonists
ZA200800405B
(en )
2008-12-31
Pyrisazinone derivatives as thyroid hormone receptor agonists
IL208355A0
(en )
2010-12-30
Heterocyclic copmpounds as adenosine receptor antagonist
ZA201103154B
(en )
2012-01-25
Melanocortin receptor agonists
EP2032797A4
(en )
2011-03-16
Adenosine a2b receptor antagonists
IL210773A0
(en )
2011-03-31
Neuropeptide-2 receptor (y-2r) agonists and uses thereof
EP2017281A4
(en )
2012-03-14
Toll-like receptor 9 agonists
EP2191830A4
(en )
2011-11-23
Solid preparation comprising npyy5 receptor antagonist
EP2222676A4
(en )
2011-10-26
A1 adenosine receptor antagonists
EP2326175A4
(en )
2011-09-28
Allosteric enhancers of the a1 adenosine receptor
ZA200606223B
(en )
2008-07-30
Myocardial persufion imaging using adenosine receptor agonists
IL177721A0
(en )
2006-12-31
Adenosine receptor agonists
GB0720388D0
(en )
2007-11-28
G-protein coupled receptor agonists
GB0605861D0
(en )
2006-05-03
A2B adenosine receptor antagonists
GB0705379D0
(en )
2007-04-25
A2b adenosine receptor antagonists